Improvement of DAS-28 ESR score in Egyptian children and adolescents with juvenile idiopathic arthritis treated with etanercept

Improvement of DAS-28 ESR score in Egyptian children and adolescents with juvenile idiopathic arthritis treated with etanercept

Aim of study: To assess the efficacy and safety of using anti-tumor necrosis factor-α (TNF-α), Etanercept (ETN) in treatment of children and adolescents with Juvenile Idiopathic arthritis (JIA). Patients and methods: This retrospective cohort study included 18 children and adolescents who were diagn...

Full description

Bibliographic Details
Main Authors: Rasha Abdel-Raouf Afifi, Heba Taher Osman, Walaa Aboulkasem Shahin, Menna-t-allah Alaa ElDin Yousef
Format: Article
Language:English
Published: SpringerOpen 2017-07-01
Series:Egyptian Pediatric Association Gazette
Subjects:
Juvenile idiopathic arthritis
DAS28-ESR
Anti-tumor necrosis factor-α
Etanercept
Online Access:http://www.sciencedirect.com/science/article/pii/S1110663816300751

Internet

http://www.sciencedirect.com/science/article/pii/S1110663816300751

Similar Items